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Abstract
Background: Heme oxygenase-1 (HO-1) is induced in many cell types as a defense mechanism against stress. We have
investigated the possible role of endogenous HO-1 in the effector phase of arthritis using the K/BxN serum transfer model of
arthritis in HO-1 heterozygous and homozygous knock-out mice.
Methodology/Principal Findings: Arthritis was induced in C57/Black-6 xFVB (HO-1+/+, HO-1+/2 and HO-12/2) mice by
intraperitoneal injection of 150 ml serum from arthritic K/BxN mice at days 0 and 2. Blood was collected and animals were
sacrificed at day 10. Histological analysis was performed in ankle sections. The levels of inflammatory mediators were
measured in serum and paw homogenates by enzyme-linked immunosorbent assay or Multiplex technology. The incidence
of arthritis was higher in HO-1+/2 and HO-12/2 groups compared with HO-1+/+. The inflammatory response was aggravated
in HO-1+/2 mice as shown by arthritic score and the migration of inflammatory cells that could be related to the
enhancement of CXCL-1 production. In addition, the HO-1+/2 group showed proteoglycan depletion significantly higher
than HO-1+/+ mice. Serum levels of matrix metalloproteinase-3, monocyte chemotactic protein-1, plasminogen activator
inhibitor-1, E-selectin and intercellular adhesion molecule-1 were increased in arthritic HO-12/2 mice, whereas vascular
endothelial growth factor and some cytokines such as interferon-c showed a reduction compared to HO-1+/+ or HO-1+/2
mice. In addition, down-regulated gene expression of ferritin, glutathione S-reductase A1 and superoxide dismutase-2 was
observed in the livers of arthritic HO-1+/2 animals.
Conclusion/Significance: Endogenous HO-1 regulates the production of systemic and local inflammatory mediators and
plays a protective role in K/BxN serum transfer arthritis.
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Introduction
Results of previous studies indicate that heme oxygenase-1 (HO-
1) induction plays a role in protecting tissues against injury
through the modulation of oxidative stresss or cellular activation
[1]. Conversely, HO-1 deficiency has revealed an important role
for this enzyme in immune responses [2]. Expression levels of HO-
1 are excessively increased in patients with some inflammatory
diseases suggesting its participation in the development of systemic
inflammation [3]. However, little is known about the role of HO-1
in arthritic disorders. An association of HO-1 promoter poly-
morphism with rheumatoid arthritis (RA) has been reported [4]
and patients with the SS genotype, resulting in a higher HO-1
expression, may have a better long-term radiographic outcome
despite disease activity [5]. HO-1 protein is expressed in synovial
tissues of RA patients [6] and its presence in synovial fluid may be
a marker of joint inflammation [7] Nevertheless, treatment of RA
patients with tumor necrosis factor a (TNF-a) antagonists may
block the TNF-a-dependent suppression of HO-1 expression in
peripheral blood cells, resulting in amelioration of inflammation
[8].
There is emerging evidence that pharmacological induction of
HO-1 results in anti-inflammatory effects in models of RA [9,10].
Metabolites derived from HO-1 activity such as biliverdin/
bilirubin or carbon monoxide (CO) may be responsible for the
anti-inflammatory actions of this enzyme. In particular, CO may
mediate the main actions of HO [11,12]. In arthritic processes, we
have shown that administration of the CO-releasing molecule
CORM-3 results in the down-regulation of the inflammatory
response in the collagen-induced [13] and K/BxN serum transfer
[14] arthritis models.
Metalloporphyrin inhibitors of HO-1 exhibit a number of
nonspecific effects [15], [16] and therefore they have limitations in
assessing the role of endogenous HO-1. However, the use of
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genetically deficient mice can provide a better insight into the
possible regulatory effects of HO-1 in inflammatory responses.
Studies in HO-12/2 mice have revealed that HO-1 deficiency
favors the production of Th1 cytokines by stimulated splenocytes
suggesting a pro-inflammatory tendency [17]. In addition, the
apparent defect in immune regulation in HO-12/2 mice may be
related to the inhibition of Treg suppressive activity [18]. Transfer
of serum from K/BxN transgenic mice into healthy animals
induces an autoimmune and inflammatory response mediated by
IgG1 autoantibodies with a number of similarities to human RA
[19], [20]. In this study, we have investigated whether endogenous
HO-1 would play a role in the effector phase of inflammatory
arthritis by inducing K/BxN serum transfer arthritis in HO-1 wild




Figure 1A shows the time-course of macroscopic score values
and arthritis incidence. Representative images of hind paws and
front paws from all experimental groups at the end of the
experiment are shown in Figure 1B. In mice injected with K/BxN
serum inflammation increased progressively with time. We noted
that HO-1+/2 and HO-12/2 mice developed accelerated arthritis
compared with HO-1+/+ animals. Arthritic score values were also
increased in both groups although they reached statistical
significance in HO-1+/2 mice only.
Histological Analysis
In arthritic animals, ankle sections showed the presence of
inflammatory cells, synovial hyperplasia and cartilage destruction
(Figure 2). There was a two-fold increase in synovial infiltration
and accumulation of inflammatory cells in joint spaces in arthritic
HO-1+/2 compared to HO-1+/+ mice. The values for HO-12/2
animals also increased although to a lower extent. In addition, the
HO-1+/2 group showed proteoglycan depletion scores higher than
those of HO-1+/+ mice.
Blood Determinations
Naı̈ve HO-12/2 mice showed increased counts of lymphocytes,
granulocytes and monocytes with respect to HO-1+/+ or HO-1+/2
animals (Table 1) which were also observed after arthritis
induction. In contrast, a small reduction in leukocyte numbers
was observed in arthritic mice with one HO-1 allele with respect to
arthritic HO-1+/+ controls. In addition, arthritis resulted in the
production of anemia accompanied by increased platelet counts in
all groups although these effects were more pronounced in HO-
12/2 animals. Other blood parameteres were not significantly
different in either mice lacking both or one HO-1 allele with
respect to HO-1+/+ animals (data not shown). Naı̈ve HO-1+/2 and
HO-12/2 mice showed a tendency to increased serum levels of
receptor activator for nuclear factor kB ligand (RANKL) in
comparison with HO-1+/+ (Figure 3). Induction of arthritis led to
a time-dependent reduction in RANKL which was significant for
HO-1+/2 mice at day 10 and HO-12/2 animals at days 7 and 10.
We also observed that osteocalcin levels were significantly reduced
at days 4 and 7 in HO-12/2 mice with respect to HO-1+/+.
Matrix metalloproteinase-3 (MMP-3) was significantly increased in
the last group at days 4 and 7 after serum transfer in comparison
with naı̈ve mice. In HO-1 deficient mice, MMP-3 showed a similar
profile with time and its levels were significantly higher in HO-12/
2 mice than in HO-1+/+ or HO-1+/2 animals at day 7. As shown
in Figure 4, the levels of a number of inflammatory mediators
measured in serum at the end of the experiment (day 10) were
modified in HO-1 deficient animals. The levels of interleukin(IL)-
1b, interferon-c (IFN-c) and vascular endothelial growth factor
(VEGF) after arthritis induction were lower in HO-12/2 animals
with respect to HO-1+/+ or HO-1+/2 mice. IL-17 was not
significantly modified at this time point (data not shown) but its
levels measured at day 7 showed a similar profile with values
(mean6SEM) for arthritic animals of 4.860.7 pg/ml (HO-1+/+),
3.460.5 pg/ml (HO-1+/2) and 2.560.6 pg/ml (HO-12/2,
P,0.05 with respect to HO-1+/+). In contrast, arthritic HO-1
deficient mice showed higher levels of monocyte chemotactic
protein-1 (MCP-1), intercellular adhesion molecule-1 (ICAM-1),
E-selectin and plasminogen activator inhibitor-1 (PAI-1) with
respect to arthritic HO-1+/+ or HO-1+/2 animals. Serum ICAM-1
was also enhanced in naı̈ve HO-1+/2 and HO-12/2 mice
compared to naı̈ve HO-1+/+ animals. IFN-c levels in naı̈ve HO-
12/2 mice were lower than those of naı̈ve HO-1+/+ whereas
MCP-1 levels were significantly augmented. In addition, naı̈ve
mice lacking one or two HO-1 alleles showed IL-1b levels lower
than HO-1+/+ animals and arthritis induction led to a significant
increase of this cytokine in HO-1+/2 animals.
Levels of Mediators in Ankles
The production of cytokines and chemokines in the joint plays
an important role in inflammatory arthritis. Local production of
inflammatory mediators was examined in ankle homogenates.
Induction of arthritis in wild type mice resulted in increased levels
of IL-1b, TNF-a and MMP-3 at day 10 (Figure 5). There were no
differences in IL-1b, TNF-a, IL-17 or VEGF-A levels between the
different genotypes. In arthritic animals, IL-6 and MMP-3
significantly increased in HO-1+/2 and HO-12/2 mice with
respect to HO-1+/+ group. In contrast, induction of arthritis
decreased IL-10 in all three genotypes. In addition, we observed in
arthritic animals that CXCL-1 levels were significantly enhanced
in HO-1+/2 mice with respect to wild type or HO-12/2 mice. We
also determined the levels of myeloperoxidase activity as a marker
of neutrophils. No significant differences were observed between
naı̈ve HO-1+/+ and HO-1+/2 mice whereas naı̈ve HO-12/2 mice
showed a tendency to increased values. The induction of arthritis
resulted in a significant enhancement in myeloperoxidase activity
with respect to the corresponding naı̈ve animals, in HO-1+/+ and
HO-1+/2 mice but not in HO-12/2 mice. Myeloperoxidase
activity was significantly higher in arthritic HO-1+/2 mice
compared with arthritic HO-1+/+ or HO-12/2 groups.
Expression of Antioxidant Genes
Because both partial and complete HO-1 deficiency led to
increased susceptibility to arthritis but some effects were even
more pronounced in HO-1+/2 animals we checked the expression
of other than HO-1 antioxidant genes in arthritic animals of all
genotypes. Using real-time PCR we analyzed the expression of
thioredoxin-2 (Thrx-2), glutathione S-transferase-1 (GSTA-1),
glutathione reductase (GR), superoxide dismutase-2 (SOD-2),
ferritin and catalase in the livers of arthritic animals. Interestingly,
we observed that in mice which lack one HO-1 allele, but not in
the HO-12/2 animals, the expression of some antioxidant genes
was diminished. The decrease in ferritin and GSTA1 expression
was statistically significant and there was a tendency for the down-
regulation of SOD-2 (P=0.07). On the other hand, the expression
of Thrx-2, GSR and catalase was similar in mice of all genotypes
(Figure 6). The observed changes in the HO-1+/2 animals after
arthritis induction may suggest that increased susceptibility to
arthritis development may result from the decreased systemic anti-
oxidative response, not only HO-1 activity.
HO-1 in Arthritis
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Discussion
We have studied the consequences of HO-1 deficiency in an
autoantibody-mediated model of RA that bypasses the immu-
nologic phase of arthritis. Our results indicate that HO-1
deficiency aggravates the progression of K/BxN serum transfer
arthritis. An earlier initiation of arthritis and higher arthritic
score values were observed in HO-1+/2 and to a lower extent
in HO-12/2 mice compared to arthritic HO-1+/+ animals. This
animal model is dependent on the presence of neutrophils and
macrophages [20,21] with an essential role of neutrophils in the
establishment of immune complex-mediated arthritis [22]. The
histopathological analysis of the present study confirmed the
clinical findings and the higher inflammatory response in the
joints of HO-1+/2 mice compared with HO-12/2 and HO-1+/+
mice which would be dependent on the enhanced migration of
neutrophils. These local effects could be related to the
production of chemokines such as CXCL-1. It is interesting to
note that this chemokine has been reported to mediate
neutrophil recruitment to the joints of K/BxN serum transfer
arthritis and its up-regulation in ankle and synovial fluid
parallels the progression of disease [23]. Deficiency in HO-1 did
not significantly affect basal expression of mediators in the joint.
However, after induction of arthritis, we observed the local up-
regulation of pro-inflammatory IL-6 and MMP-3 in both HO-
1+/2 and HO-12/2 animals with respect to wild type mice.
HO-1 deficiency also affected serum levels of RANKL and
osteocalcin in arthritic animals with stronger effects for the HO-
12/2 genotype. Our results thus suggest a role for HO-1 in
osteoblast function during the course of arthritis.
Serum levels of IL-1b and IFN-c were lower in arthritic HO-
12/2 animals compared with arthritic HO-1+/2 and HO-1+/+
mice. Given the important role of IL-1b in K/BxN in-
flammation [24], the absence of enhancing effects on this
cytokine may contribute to the lower arthritic response observed
in HO-12/2 animals compared with HO-1+/2 mice. In
addition, IFN-c may play a complex role in this experimental
model as administration of low doses of this cytokine exerts
inhibitory effects on arthritis [25]. The absence of HO-1
resulted in higher serum MCP-1 levels compared to HO-1+/+
mice. This observation is consistent with previous studies
showing that the protective effects of HO-1 in injured renal
tissues may depend on HO-1 ability to restrain up-regulation of
MCP-1 [26]. Induction of arthritis in HO-12/2 mice but not in
HO-1+/2 animals significantly increased serum levels of MMP-
3, PAI-1, E-selectin and ICAM-1 whereas VEGF levels were
lower than those of HO-1+/+ or HO-1+/2 mice. Similar
observations on PAI-1 increased expression were made in
mouse embryonic HO-1 deficient cells [27]. In HO-12/2 mice,
Figure 1. Evolution of arthritis. A, Time-course of clinical score values (mean 6 SEM) and arthritis incidence (% of mice with arthritis), (n= 10
animals per group). *P,0.05, **P,0.01, ***P,0.001 with respect to the arthritic HO-1+/+ group. B, Pictures of representative paws taken at the end of
the experiment (day 10).
doi:10.1371/journal.pone.0052435.g001
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Figure 2. Histological analysis of frontal sections of ankle joints at day 10. A–F: hematoxylin and eosin-stained sections, and G–R: safranin
O and fast green-stained sections. C= cartilage; CA= calcaneous; JS = joint space; S = synovium; T = tibia. B, D and F: solid arrows indicate areas of cell
infiltration and broken arrows indicate exudate. N and P: solid arrows indicate proteoglycan depletion in cartilage matrix. The histological scores are
presented as mean 6 SEM (n= 4–10). *P,0.05, **P,0.01, each arthritic group compared to its respective naı̈ve group. #P,0.05 with respect to
arthritic HO-1+/+ group.
doi:10.1371/journal.pone.0052435.g002
















HO-1+/+ 17.164.2 13.563.9 0.760.2 3.960.4 7.260.8 17.363.3 10.560.7
HO-1+/2 17.162.2 13.563.0 0.660.1 3.060.6 6.961.0 18.062.0 9.263.2
















HO-1+/+ 16.963.5 12.362.7 0.760.2 3.961.0 5.260.7** 14.861.7 12.662.3
HO-1+/2 12.963.2*# 9.462.0**# 0.560.2 2.961.2 5.560.6* 14.761.4** 14.061.1**
HO-12/2 33.3614.3#+ 22.168.6#++ 1.5.160.8##++ 9.765.7 5.560.8** 12.361.8**#+ 15.561.5**#
Results show mean6S.D. *P,0.05, **P,0.01 versus the corresponding naı̈ve group; #P,0.05, ##P,0.01 versus HO-1+/+ in the same group; +P,0.05, ++P,0.01 versus
HO-1+/2 in the same group.
doi:10.1371/journal.pone.0052435.t001
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enhanced serum ICAM-1, E-selectin, and MMP-3 levels in-
dicate the presence of vasculitis and systemic inflammation. Our
data in this animal model of RA are in line with the results of
previous studies showing that HO-1 exhibits anti-inflammatory
and protective effects against organ injury by inhibiting the
expression of adhesion molecules [28,29] and MCP-1 [26]
besides promoting vascular repair through VEGF production
[30].
The mechanism by which HO-1 deficiency modulates the
effector phase of arthritis is complex. In this study, HO-1+/2
and HO-12/2 mice showed a higher susceptibility to develop
arthritis after K/BxN serum transfer when compared with their
wild type counterparts. Nevertheless, the inflammatory response
in the joint was more aggressive in animals lacking one HO-1
allele with respect to complete HO-1 absence. To elucidate this
effect we measured the expression of other than HO-1
antioxidant genes in the livers of the affected animals. In-
Figure 3. Time-course of RANKL, osteocalcin and MMP-3 levels in serum. Data represent mean 6 SEM, n= 4–10. *P,0.05, **P,0.01 each
arthritic group compared with its respective naı̈ve group, #P,0.05, ##P,0.01 with respect to arthritic HO-1+/+ group.
doi:10.1371/journal.pone.0052435.g003
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terestingly, we observed a significant reduction of ferritin and
GSTA1 and a trend to down-regulation of SOD-2 expression in
HO-1+/2 animals only. These genes are part of interactive
defense mechanisms that allow adaptation to oxidative stress
exposure and result in anti-inflammatory effects [31–34]. Such
differential expression of antioxidant enzymes after stressful
conditions in mice with different HO-1 levels was previously
observed by us in another model [35]. Thus, in mice subjected
to chemical induction of squamous cell carcinoma, the
expression of catalase and GR was decreased only in HO-1+/
2 mice and was not affected in HO-1 knock-out animals [35].
The partial loss of antioxidant and antiinflammatory protection
in heterozygous HO-1 mice may contribute to the development
of an inflammatory response more aggressive than in wild type
mice. Nevertheless, the strong loss of HO-1 in knock-out mice
may be a stimulus leading to the partial activation of other
defense systems during stressful situations such as arthritis
induction. As a result, the inflammatory response was up-
regulated to a lower extent. These observations suggest that
HO-1 knock-out mice might be able to develop compensatory
mechanisms against stress, but the lack of only one allele of
HO-1 may not be sufficient to initiate such a response.
Genetically decreased basal HO-1 levels in HO-1+/2 mice can
represent a more physiological situation than total HO-1 deletion
as HO-1 has a role in maintaining the body homeostasis. It is
known that HO-12/2 mice develop with time a number of
changes indicating defects in immune regulation, the presence of
a chronic inflammatory state and organ damage [17,18,36]. These
results in the K/BxN serum transfer model of arthritis indicate
that HO-1 absence deregulates homeostasis of leukocytes either in
naı̈ve or arthritic animals as well as vascular homeostasis leading to
systemic inflammation during the development of the effector
phase of arthritis which may influence the response to K/BxN
serum. Therefore, an altered production of cytokines and
chemokines which critically determine leukocyte circulating
numbers, cell activation and tissue infiltration could promote
systemic inflammatory changes in HO-12/2 mice that may limit
the joint response. In particular, the presence in these mice of high
serum levels of MCP-1 and PAI-1 may determine vascular
disfunction with recruitment of inflammatory cells into neointima,
hyperplasia and a procoagulant state [26].
In conclusion, deficiency of HO-1 in heterozygous animals
potentiates arthritis due to the up-regulation of cytokines and
chemokines relevant for neutrophil migration and joint inflam-
mation, whereas deletion of HO-1 results in systemic inflammation
leading to a lower ability to potentiate local joint inflammation.
Our findings point to a modulatory role of endogenous HO-1 in
Figure 4. Levels of inflammatory mediators in serum at day 10. Data represent mean 6 SEM, n= 4–10. N (naı̈ve); Ar. (arthritic). *P,0.05,
**P,0.01 each arthritic group compared with its respective naı̈ve group, #P,0.05, ##P,0.01 with respect to arthritic HO-1+/+ group, ++P,0.01 with
respect to arthritic HO-1+/2 group, &P,0.05 with respect to naı̈ve HO-1+/+ group.
doi:10.1371/journal.pone.0052435.g004
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Figure 5. Levels of inflammatory mediators in ankle homogenates at day 10. Data represent mean 6 SEM, n= 4–10. N (naı̈ve); Ar. (arthritic).
*P,0.05, **P,0.01 each arthritic group compared with its respective naı̈ve group, #P,0.05, ##P,0.01 with respect to arthritic HO-1+/+ group,
+P,0.05 with respect to arthritic HO-1+/2 group.
doi:10.1371/journal.pone.0052435.g005
Figure 6. Gene expression levels at day 10. Relative mRNA levels of glutathione S-transferase A1 (GSTA1), glutathione reductase (GSR), ferritin,
thioredoxin-2 (Thxr-2), superoxide dismutase-2 (SOD-2) and catalase were measured in livers of arthritic mice at day 10 by real-time PCR. Results were
normalized with respect to elongation factor 2 (EF2) and expressed as 22DCt. Data represent mean 6 SEM, n= 8–9. #P,0.05, ##P,0.01 compared
with arthritic wild type animals.
doi:10.1371/journal.pone.0052435.g006
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the effector phase of arthritis and provide new insights into the
anti-inflammatory properties of HO-1.
Methods
Ethics Statement
All studies were performed in accordance with European Union
regulations for the handling and use of laboratory animals. The
protocols were approved by the institutional Animal Care and Use
Committees (Jagiellonian University, Krakow, Poland and Comité
Etico de Bienestar y Experimentación Animal, University of Valencia,
Spain, A1264890323968).
Induction of Arthritis
Experiments were performed on 20–27-week-old male C57/
Black-6 xFVB (HO-1+/+, HO-1+/2 and HO-12/2) mice gener-
ated from the HO-1+/2 breeding pair kindly gifted by Dr.
Anupam Agarwal (Birmingham, AL, USA). Mice were genotyped
three weeks after birth by PCR using tail DNA as previously
described [36]. All mice were maintained in cages with a 12-hour
light/dark cycle, at 22uC and free access to sterilized food and
water. Mice were housed and cared for by the veterinary staff and
were routinely screened for health status. Animals were assigned to
experimental groups (n=10 in arthritic groups and n=4 in naı̈ve
groups): arthritic HO-1+/+, arthritic HO-1+/2, arthritic HO-12/
2, naı̈ve HO-1+/+, naı̈ve HO-1+/2 and naı̈ve HO-12/2. Arthritis
was induced by intraperitoneal injection of serum (150 ml) from
arthritic K/BxN mice (generated by crossing KRN-TCR-trans-
genic mice (B10.BR genetic background) with NOD mice) at days
0 and 2. Blood was collected from the retroorbital venous plexus at
days 4, 7 and 10, as well as from tail at day 10, and animals were
sacrificed by cervical dislocation at day 10. Ankles from randomly
selected animals in each group were isolated for histological
analysis and the rest of them were used for measurement of
inflammatory markers.
Arthritis Score
The clinical severity of arthritis was graded using a scale of 0–2
for each paw where 0= uninflamed, 1=mild, 1.5 =marked and
2= severe inflammation, and the four-limb scores were summed to
yield the clinical index. Scoring was performed by two in-
dependent observers without knowledge of the experimental
groups.
Histological Analysis
For standard histological assessment, isolated ankles were kept
in 4% formalin in phosphate-buffered saline for 4 days, decalcified
in 5% formic acid or 10% EDTA, and subsequently dehydrated
and embedded in paraffin. Standard frontal sections (7 mm) of the
joint tissue were mounted on SuperFrost slides (Menzel-Gläser,
Braunschweig, Germany). Hematoxylin and eosin staining was
performed to study joint inflammation. The severity of in-
flammation in the joints was scored on a scale of 0–3 (0 = no
cells, 1 =mild cellularity, 2 =moderate cellularity, and 3=maxi-
mal cellularity). To study proteoglycan depletion from the
cartilage matrix, sections were stained with safranin O, followed
by counterstaining with fast green. Depletion of proteoglycan was
determined using an arbitrary scale of 0–3, ranging from normal,
fully stained cartilage to destained cartilage that was fully depleted
of proteoglycan. Histopathologic changes were scored on three
semiserial sections of the joint, with sections spaced 70 mm apart.
Scoring was performed in a blind manner by two independent
observers. Sections were examined under a light microscope
Eclipse E800, (Nikon Instruments Europe, Amstelveen, The
Netherlands) and photographed with a Nikon Digital Camera
DXM1200 using the software Nikon ACT-1.
Blood Determinations
Blood samples collected from tails at day 10 were analyzed using
an automatic blood analyzer (Scil Vet ABC HORIBA ABX., UK).
The following parameters have been determined: white blood cell
(WBC) count, differential leukocyte count, red blood cell (RBC)
count, hemoglobin concentration, hematocrit, platelet count,
mean corpuscular volume, mean corpuscular hemoglobin, and
mean corpuscular hemoglobin concentration. Blood samples were
centrifuged at 10,0006g for 10 min at 4uC to separate the serum.
Cytokine content in the mouse serum was analyzed using
multiplex Luminex technology. The concentration of IL-1b, IL-
6, IL-17, IFN-c, MCP-1, TNF-a and VEGF was measured
according to the manufacturer’s instructions (Millipore, Billerica,
MA, USA) with sensitivity of 2.0, 1.8, 0.5, 0.9, 5.3, 1.0 and 0.3 pg/
ml, respectively. In addition, the levels of E-selectin, ICAM-1 and
PAI-1 with sensitivity of 5.0, 3.0 and 2.0 pg/ml, respectively, have
been assessed. Data were analyzed using a Flexmap 3D instrument
and Luminex xPONENTH 4.0 Software and Luminex Analyst
Program (Luminex Corporation, Austin, Texas, USA). The levels
of osteocalcin and RANKL in serum were determined by the
LINCOplexTM system (Millipore Iberica, Madrid, Spain), with
sensitivity of 7.0 and 3.0 pg/ml, respectively. MMP-3 levels were
measured by ELISA (R&D Systems Europe Ltd., Abingdon, UK),
with sensitivity of 19.0 pg/ml.
Measurement of Inflammatory Mediators in Paw
Homogenate
Ankles were amputated and homogenized in liquid N2 with
1 ml of A buffer pH 7.46 (10 mM HEPES, pH 8, 1 mM EDTA,
1 mM EGTA, 10 mM KCl, 1 mM dithiothreitol, 5 mM NaF,
1 mM Na3VO4, 1 mg/ml leupeptin, 0.1 mg/ml aprotinine and
0.5 mM phenylmethyl sulfonyl fluoride). The tissue homogenates
obtained were sonicated (3610 sec) and centrifuged at 12006g,
10 min at 4uC. Supernatants were removed and used for
determination of mediators. TNF-a and IL-1b were determined
by ELISA (R&D Systems Inc., Minneapolis, MN, USA) with
a range of detection of 32–2700 and 25–2000 pg/ml, respectively.
IL-6, IL-10 and VEGF-A were measured using the ELISA kits
from eBioscience Inc. (San Diego, CA, USA), with sensitivity of
4.0, 30.0 and 20.0 pg/ml, respectively. IL-17 and MMP-3 were
determined by ELISA kits from R&D Systems Europe Ltd.
(Abingdon, UK) with sensitivity of 5.0 and 19.0 pg/ml, re-
spectively. CXCL-1 was determined by ELISA (Promokine,
PromoCell GmbH, Heidelberg, Germany, 8–1000 pg/ml). Mye-
loperoxidase activity was assayed as described previously [37].
RNA Isolation and Real-time PCR
Fragments of livers isolated from arthritic animals were
homogenized in 1 ml of Qiazol (Qiagen GmbH, Hilden,
Germany) and mixed with 200 ml of chloroform. The obtained
lysates were vortexed, incubated on ice for 15 min, and
centrifuged (20 min, 10,000g, 4uC). Then, an upper aqueous
phase was collected and subjected to ethanol precipitation. The
RNA pellets were dissolved in nuclease-free water. Reverse
transcription was performed on 2 mg of total RNA for 1 h at
42uC using oligo(dT) primers (Promega Corporation, Madison,
WI, USA) and RevertAid reverse transcriptase (Thermo Scientific,
Erembodegem, Belgium). Real-time PCR was carried out using
StepOnePlusTM Real-Time PCR Systems (Applied Biosystems,
Carlsbad, CA, USA) in a mixture containing SYBR Green PCR
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Master Mix (Sigma-Aldrich, St. Louis, MO, USA), specific
forward and reversed primers (Table S1) and 50 ng of cDNA.
EF2 (elongation factor 2) was used as a housekeeping gene.
Comparison of gene expression in different samples was
performed using DCt method.
Statistical Analysis
Differences between experimental groups were tested using the
two-tailed Mann-Whitney U test. P values less than 0.05 were
considered significant.
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